戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 te of the ACT-domain of the Escherichia coli phosphoglycerate dehydrogenase.
2 xtracts of M. maripaludis were shown to have phosphoglycerate dehydrogenase and phosphoserine aminotr
3       The inhibition of Escherichia coli d-3-phosphoglycerate dehydrogenase by l-serine is positively
4 etate methyltransferase deficiency and for 3-phosphoglycerated dehydrogenase deficiency appear promis
5                                          D-3-phosphoglycerate dehydrogenase (EC 1.1.1.95) from Escher
6                                          D-3-Phosphoglycerate dehydrogenase (EC 1.1.1.95) from Escher
7                                              Phosphoglycerate dehydrogenases exist in at least three
8 resents a second structural motif of the D-3-phosphoglycerate dehydrogenase family, one that contains
9                   The binding of L-serine to phosphoglycerate dehydrogenase from E. coli displays ele
10                                          d-3-Phosphoglycerate dehydrogenase from Escherichia coli con
11                                          d-3-Phosphoglycerate dehydrogenase from Escherichia coli is
12                                          D-3-Phosphoglycerate dehydrogenase from Escherichia coli is
13    The heterologously expressed and purified phosphoglycerate dehydrogenase from M. maripaludis had e
14                                          D-3-Phosphoglycerate dehydrogenase from Mycobacterium tuberc
15                 The crystal structure of D-3-phosphoglycerate dehydrogenase from Mycobacterium tuberc
16  structure of Mycobacterium tuberculosis d-3-phosphoglycerate dehydrogenase has been solved with boun
17 10 interacted with the chloroplastic protein phosphoglycerate dehydrogenase in a yeast (Saccharomyces
18                                            3-Phosphoglycerate dehydrogenase is an exclusively astrocy
19 that predicts that catalytic activity in D-3-phosphoglycerate dehydrogenase is regulated by the movem
20                                          D-3-Phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95) from
21 e catalytic activity of Escherichia coli D-3-phosphoglycerate dehydrogenase (PGDH) by binding to its
22                                              Phosphoglycerate dehydrogenase (PGDH) catalyzes the firs
23                           Escherichia coli 3-phosphoglycerate dehydrogenase (PGDH) catalyzes the firs
24                    An active conformation of phosphoglycerate dehydrogenase (PGDH) from Escherichia c
25                                          D-3-Phosphoglycerate dehydrogenase (PGDH) from Escherichia c
26 ructural homology with the ASB domain of d-3-phosphoglycerate dehydrogenase (PGDH) from Mycobacterium
27                                          D-3-Phosphoglycerate dehydrogenase (PGDH) from Mycobacterium
28 ric hybrid tetramers of Escherichia coli d-3-phosphoglycerate dehydrogenase (PGDH) have been made by
29 topped-flow analysis of Escherichia coli d-3-phosphoglycerate dehydrogenase (PGDH) reveals that the p
30 ol coefficient for the branch point enzyme 3-phosphoglycerate dehydrogenase (PGDH).
31 ding for the first enzyme of this pathway, 3-phosphoglycerate dehydrogenase (PGDH).
32 ulatory and substrate binding domains of D-3-phosphoglycerate dehydrogenase (PGDH, EC 1.1.1.95) from
33 e, we present a detailed characterization of phosphoglycerate dehydrogenases (PGDHs) as components of
34  with the ASB domain like that in type 1 D-3-phosphoglycerate dehydrogenases (PGDHs).
35 nately regulate expression of genes encoding phosphoglycerate dehydrogenase (PHGDH) and five downstre
36                  Enzymes of the SSP, such as phosphoglycerate dehydrogenase (PHGDH) and phosphoserine
37                  Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic r
38                                              Phosphoglycerate dehydrogenase (PHGDH) is the metabolic
39  BA, but not GH, caused a 2-fold increase in phosphoglycerate dehydrogenase (PHGDH) protein expressio
40 mes of the de novo serine synthesis pathway (phosphoglycerate dehydrogenase (PHGDH), phosphoserine am
41 uman cancers often exhibit overexpression of phosphoglycerate dehydrogenase (PHGDH), the metabolic en
42               The gene encoding the enzyme 3-phosphoglycerate dehydrogenase (PHGDH), which catalyzes
43 d into serine and glycine metabolism through phosphoglycerate dehydrogenase (PHGDH).
44                                          d-3-Phosphoglycerate dehydrogenase (Phgdh; EC 1.1.1.95) is t
45 of residues in the regulatory domains of D-3-phosphoglycerate dehydrogenase provide the first direct
46                 The crystal structure of d-3-phosphoglycerate dehydrogenase reveals a limited number
47                                The first D-3-phosphoglycerate dehydrogenase structure to be determine
48                       In Escherichia colid-3-phosphoglycerate dehydrogenase, the amino acid sequences
49 n part to the genomic copy number gain for 3-phosphoglycerate dehydrogenase, the enzyme that controls
50                  Consistently, inhibition of phosphoglycerate dehydrogenase, the first enzyme of the
51 sphate pathway (PPP), while 2-PG activates 3-phosphoglycerate dehydrogenase to provide feedback contr
52               Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase undergoes significant inh
53 topped flow analysis of Escherichia coli D-3-phosphoglycerate dehydrogenase was performed by followin
54  and mice with targeted deletion of Srr or 3-Phosphoglycerate dehydrogenase, we demonstrate predomina
55  same fold; (iii) the C-terminal domain of 3-phosphoglycerate dehydrogenase, which binds serine and i
56 e structure of a truncated form of human d-3-phosphoglycerate dehydrogenase with cofactor and a subst

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。